A DOENÇA DE CROHN EM DECORRÊNCIA DA DESREGULAÇÃO DO SISTEMA IMUNOLÓGICO
DOI:
https://doi.org/10.47820/recima21.v3i8.1844Keywords:
''immune system'', ''crohn's disease''Abstract
Introduction: Crohn's disease (CD) is an incurable inflammatory bowel disease in which occurs inflammation and ulceration of the mucosa in the gastrointestinal tract. The lymphocytes of the immune system control the inflammatory process by causing an excessive increase in pro-inflammatory cytokines. Objective: To analyze the influence of the immune system on the origin and development of CD. Materials and Methods: An integrative literature review was performed, aiming to correlate the immune system with CD. For data analysis, clinical study, clinical trial, comparative study, meta-analysis, multicenter study, observational study, and randomized controlled trial were included. Articles from the Pubmed database, published between the years 2018 through 2022, were used for this study. The descriptors chosen were "crohn 's disease" and "immune system". Books and documents, reviews and systematic reviews were excluded. After inclusion and exclusion criteria, 28 articles were selected. Results: Cytokines and chemokines released from the increase of neutrophils will increase the severity of inflammation. In this process interleukin-1, interleukin-6 and tumor necrosis factor-α will be expressed. Conclusion: The immune system has a strong relation with the progression of CD from an imbalance in the production of defense cells, triggering immunological lesions and prominent infiltrations of these cells.
Downloads
References
ALEXANDER, Katie L. et al. Human microbiota flagellins drive adaptive immune responses in Crohn’s disease. Gastroenterology, v. 161, n. 2, p. 522-535. e6, 2021.
ROSEN, Michael J. et al. Mucosal expression of type 2 and type 17 immune response genes distinguishes ulcerative colitis from colon-only Crohn’s disease in treatment-naive pediatric patients. Gastroenterology, v. 152, n. 6, p. 1345-1357. e7, 2017.
SINNIGER, Valerie et al. A 12‐month pilot study outcomes of vagus nerve stimulation in Crohn's disease. Neurogastroenterology & Motility, v. 32, n. 10, p. e13911, 2020.
GLOBIG, Anna-Maria et al. Ustekinumab inhibits T follicular helper cell differentiation in patients with Crohn’s disease. Cellular and Molecular Gastroenterology and Hepatology, v. 11, n. 1, p. 1-12, 2021.
HE, Liwen et al. Protective association of TNFSF15 polymorphisms with Crohn's disease and ulcerative colitis: A meta-analysis. Saudi Journal of Gastroenterology: Official Journal of the Saudi Gastroenterology Association, v. 24, n. 4, p. 201, 2018.
BOURGONJE, Arno R. et al. Increased fecal calprotectin levels in Crohn’s disease correlate with elevated serum Th1-and Th17-associated cytokines. PLoS One, v. 13, n. 2, p. e0193202, 2018.
DA SILVA, Francesca Aparecida Ramos et al. Whole transcriptional analysis identifies markers of B, T and plasma cell signaling pathways in the mesenteric adipose tissue associated with Crohn’s disease. Journal of translational medicine, v. 18, n. 1, p. 1-14, 2020.
BAKOUNY, Z. et al. Platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios in Crohn's disease: The controversy remains. Clinics and Research in Hepatology and Gastroenterology, v. 42, n. 1, p. e16-e18, 2017.
SEKIDO, Yuki et al. Some Gammaproteobacteria are enriched within CD14+ macrophages from intestinal lamina propria of Crohn’s disease patients versus mucus. Scientific reports, v. 10, n. 1, p. 1-8, 2020.
SNOWDEN, John A. et al. Autologous stem cell transplantation in refractory Crohn’s disease–low intensity therapy evaluation (ASTIClite): study protocols for a multicentre, randomised controlled trial and observational follow up study. BMC gastroenterology, v. 19, n. 1, p. 1-14, 2019.
VISVANATHAN, Sudha et al. Selective IL-23 inhibition by risankizumab modulates the molecular profile in the colon and ileum of patients with active Crohn’s disease: results from a randomised phase II biopsy sub-study. Journal of Crohn's and Colitis, v. 12, n. 10, p. 1170-1179, 2018.
FONSECA-CAMARILLO, Gabriela et al. Differential expression of IL-36 family members and IL-38 by immune and nonimmune cells in patients with active inflammatory bowel disease. BioMed research international, v. 2018, 2018.
CAO, Brent L. et al. Systematic review and meta-analysis on the association of tuberculosis in Crohn’s disease patients treated with tumor necrosis factor-α inhibitors (Anti-TNFα). World journal of gastroenterology, v. 24, n. 25, p. 2764, 2018.
NADALIAN, Banafsheh et al. Prevalence of the pathobiont adherent‐invasive Escherichia coli and inflammatory bowel disease: a systematic review and meta‐analysis. Journal of gastroenterology and hepatology, v. 36, n. 4, p. 852-863, 2021.
FU, Wei et al. Peripheral blood neutrophil-to-lymphocyte ratio in inflammatory bowel disease and disease activity: A meta-analysis. International Immunopharmacology, v. 101, p. 108235, 2021.
KONDO, Ayano et al. Highly multiplexed image analysis of intestinal tissue sections in patients with inflammatory bowel disease. Gastroenterology, v. 161, n. 6, p. 1940-1952, 2021.
YAMAGUCHI, Natsu et al. The different roles of innate immune receptors in inflammation and carcinogenesis between races. Environmental Health and Preventive Medicine, v. 22, n. 1, p. 1-5, 2017.
COMECHE, Jose M. et al. Parenteral nutrition in patients with inflammatory bowel disease systematic review, meta-analysis and meta-regression. Nutrients, v. 11, n. 12, p. 2865, 2019.
ZIBANDEH, Noushin et al. Human dental follicle mesenchymal stem cells alleviate T cell response in inflamed tissue of Crohn’s patients. The Turkish Journal of Gastroenterology, v. 31, n. 5, p. 400, 2020.
MOTOYA, Satoshi et al. Safety and effectiveness of granulocyte and monocyte adsorptive apheresis in patients with inflammatory bowel disease in special situations: a multicentre cohort study. BMC gastroenterology, v. 19, n. 1, p. 1-15, 2019.
AMERIKANOU, Charalampia et al. Linking the IL-17A immune response with NMR-based faecal metabolic profile in IBD patients treated with mastiha. Biomedicine & Pharmacotherapy, v. 138, p. 111535, 2021.
COLETTA, Marina et al. Immunological variables associated with clinical and endoscopic response to vedolizumab in patients with inflammatory bowel diseases. Journal of Crohn's and Colitis, v. 14, n. 9, p. 1190-1201, 2020.
COOK, Laura et al. Analysis of flagellin-specific adaptive immunity reveals links to dysbiosis in patients with inflammatory bowel disease. Cellular and Molecular Gastroenterology and Hepatology, v. 9, n. 3, p. 485-506, 2020.
FABIAN, Ondrej et al. Immunohistochemical assessment of CD30+ lymphocytes in the intestinal mucosa facilitates diagnosis of pediatric ulcerative colitis. Digestive Diseases and Sciences, v. 63, n. 7, p. 1811-1818, 2018.
PAPOUTSOPOULOU, Stamatia et al. Macrophage-specific NF-κB activation dynamics can segregate inflammatory bowel disease patients. Frontiers in immunology, v. 10, p. 2168, 2019.
DAI, Shi-xue et al. Decreased CD8+ CD28+/CD8+ CD28–T cell ratio can sensitively predict poor outcome for patients with complicated Crohn disease. Medicine, v. 96, n. 26, 2017.
DAI, Shi-xue et al. CD8+ CD28+/CD8+ CD28− T cell equilibrium can predict the active stage for patients with inflammatory bowel disease. Clinics and Research in Hepatology and Gastroenterology, v. 41, n. 6, p. 693-702, 2017.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2022 RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218
This work is licensed under a Creative Commons Attribution 4.0 International License.
Os direitos autorais dos artigos/resenhas/TCCs publicados pertecem à revista RECIMA21, e seguem o padrão Creative Commons (CC BY 4.0), permitindo a cópia ou reprodução, desde que cite a fonte e respeite os direitos dos autores e contenham menção aos mesmos nos créditos. Toda e qualquer obra publicada na revista, seu conteúdo é de responsabilidade dos autores, cabendo a RECIMA21 apenas ser o veículo de divulgação, seguindo os padrões nacionais e internacionais de publicação.
